【Insights】CD38: Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment for adult patients with newly diagnosed multiple myeloma not eligible for transplant

2024-09-23

【Insights】CD40: UCB and Biogen Announce Positive Topline Results From Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus

2024-09-25

【Insights】IL-17: UCB presents new 4-year data for BIMZELX[®](bimekizumab) in moderate to severe plaque psoriasis at EADV 2024

2024-09-25

【Insights】PD-1/VEGF：GlycoMimetics enters into acquisition agreement with Crescent biopharma

2024-11-01

【Insights】CD19/CD20/CD3：GSK enters agreement to acquire CMG1A46 from Chimagen Bioscience

2024-11-01

【Insights】BTK：Sanofi Announces Positive Data from Phase III Study of BTK Inhibitor ITP

2024-11-06

【Insights】GLP-1R/GCGR/GIPR: Novo Nordisk Signs $285M GLP-1 Deal With Danish Neighbor Ascendis

2024-11-06

【Insights】AstraZeneca Announces Data from First-in-Human Phase 1 Study of AZD0486, a Novel CD19xCD3 T-Cell Activator, in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

2024-11-08

【Insights】HER2: FDA Approves Application for Phase I Clinical Trial of Paragon HER2 ADC for Solid Tumours

2024-11-08

【Insights】PD-1/VEGF BsAb : MSD Enters into Exclusive Global License for LM-299 from LaNova Medicines Ltd.

2024-11-19

【Insights】IL-23：Protagonist Announces Positive Topline Results From Phase 3 ICONIC Studies of Icotrokinra

2024-11-19

【Insights】GLP-1：Amgen’s MariTide Demonstrates 20% Weight Loss

2024-11-28

【Insights】HER2：FDA signs off on Merus' first-in-class NRG1+ cancer drug Bizengri

2024-12-06

【Insights】ROR1：Merck Sharp & Dohme Initiates Phase III Clinical Trial of ROR1 ADC

2024-12-06

【Insights】Merck Enters into Exclusive Global GLP-1：License Agreement with Hansoh Pharma for Investigational Oral GLP-1 Receptor Agonist

2024-12-19

【Insights】TL1A:Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease

2024-12-19

【News】会议邀请 | 诚邀您莅临第二十届CACLP 吉满展位号A7-2223

2024-01-08

【News】会议邀请 | 诚邀您莅临第二十届CACLP 吉满展位号A7-2223

2024-01-08

【Customer Literature】IF=13.933，Metabolism-Clinical and Experimental，山东大学附属山东省立医院，干扰慢病毒

2014-02-14

【Customer Literature】IF=13.312，International Journal of Clinical and Experimental Pathology，华东理工大学药学院，TCF/LEF-LUC报告基因质粒

2014-08-15